Core Laboratories N.V.
NYSE:CLBOil & Gas Equipment & Services
+$0.12 today
- Market cap
- $387.21M
- Beta
- 0.99
- P/E (TTM)
- 18.3
- EPS (TTM)
- $0.63
- Dividend yield
- 0.35%
Volume 0.52M
Average 0.49M
Returns on capital
Core Laboratories N.V. management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
11.2%
avg -32.2%
ROIC
6.8%
avg 10.0%
ROA
5.1%
avg 6.9%
Analysis
ROE is currently the strongest return metric at 11.2% versus its period average of -32.2%. 1 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Lawrence V. Bruno | Chairman of the Board, Chief Executive Officer, President & Chief Operating Officer | USD 1.48M | 66 | — | — |
Christopher Scott Hill | Senior Vice President & Chief Financial Officer | USD 668.92K | 56 | 70.01K | 0.15% |
Mark Damian Tattoli | Senior Vice President, Secretary & General Counsel | USD 576.76K | 54 | 250 | <0.01% |
Gwendolyn Y. Gresham | Senior Vice President of Corporate Development & Investor Relations | USD 574.57K | 58 | — | — |
Leslie Linklater | Vice President of People, Organization & Culture | — | — | — | — |
Sow Hang Teo | Vice President, Treasurer & Chief Accounting Officer | — | 56 | 6.00K | 0.01% |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Oct 1, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$53,900.00
Sells
0
$0.00
Net Transaction Value
+$53,900.00
Net buying
Most Active
Bruno Lawrence
1 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Jul 31, 26Jul 31, 2026 | Bruno Lawrence Direct | Buy | $53.9K$53,900.00 |
Summary
Insiders reported 1 buys worth $53,900.00 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $53,900.00. Bruno Lawrence was the most active insider with 1 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | +17.4% | +10.0% (3yr)1 analysts |
| Revenue | N/A | N/A | +2.4% | +1.7% (3yr)1 analysts |
| Net Income | N/A | N/A | +15.1% | +12.3% (3yr)1 analysts |
| EBIT | N/A | N/A | +6.7% | +13.5% (3yr)1 analysts |
Analysis
Recent growth has been strongest in EPS at +17.4% over three years. Forward estimates point to EBIT at +13.5% (3yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Core Laboratories N.V. compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about CLB's management, answered from reported figures.
Who manages CLB?
Core Laboratories N.V. (CLB) lists 6 active executives. The top listed executive is Leslie Linklater, Vice President of People, Organization & Culture.
Are CLB insiders buying or selling?
Recent insider activity shows net selling of $6.44M.
Continue the stock analysis
Jump to another research area for this company.